Cytokine Signalling Forum

Latest Podcasts


Author Interview: Professor Peter Taylor

Professor Peter Taylor, from the University of Oxford in the UK.

28th April 2022

Discussing Rheumatology: Pain, pneumonia and perspectives

Prof Iain McInnes reviews three papers this month!

28th April 2022

Discussing Rheumatology Podcast March 2022

Prof Iain McInnes reviews two papers this month, both focusing on JAKi and Rheumatoid Arthritis

12th April 2022

Author Interview: Professor Roy Fleischmann – March 2022

Professor Roy Fleishmann, clinical professor of medicine at the University of Texas Southwestern Medical Center.

16th March 2022

Author Interview: Professor Rüdiger Müller

Professor Rüdiger Müller, Rheumazentrum Ostschweiz, Switzerland

24th February 2022

Discussing Rheumatology: Tofacitinib safety and dose-switching in RA

Prof Iain McInnes reviews two papers this month, both on tofacitinib. The first looks at CV outcomes from the STAR-RA study, the second is a post-hoc analysis of ORAL Sequel looking into tofacitinib dose switching.

24th February 2022

ORAL Surveillance Author Interview – Roy Fleischmann

Professor Roy Fleishmann, clinical professor of medicine at the University of Texas Southwestern Medical Center.

09th February 2022

Author Interview: Professor Kevin Winthrop (January 2022)

Professor Kevin Winthrop, Professor of Medicine at Oregon Health & Science University.

03rd February 2022

Discussing Rheumatology: HZ and ILD with tofacitinib in RA

Prof Iain McInnes reviews two papers this month, and discusses the risk of herpes zoster (HZ) events in patients with RA treated with tofacitinib, as well as interstitial lung disease, an extra-articular manifestation of RA.

27th January 2022

Discussing Rheumatology: Safety of filgotinib, and tofacitinib in pJIA

Prof Iain McInnes reviews two papers this month, and discusses exposure-adjusted incidence rates of TEAEs and AESIs with filgotinib, as well as the efficacy and safety of tofacitinib in pJIA.

23rd December 2021

Author Interview: Professor Kevin Winthrop (December 2021)

Professor Kevin Winthrop, Professor of Medicine at Oregon Health & Science University.

23rd December 2021

Author Interview: Professor Kevin Winthrop (November 2021)

Professor Kevin Winthrop, Professor of Medicine at Oregon Health & Science University.

22nd December 2021

Author Interview: Professor Atul Deodhar

Professor Atul Deodhar, professor of medicine at Oregon Health & Science University.

06th December 2021

Discussing Rheumatology: Risk of HZ with UPA, and JAKs in SpA

Prof Iain McInnes reviews two papers this month, and discusses the increased risk of HZ infection with upadacitinib, as well as the role of the JAK-STAT pathway in SpA pathenogenesis.

06th December 2021

Author Interview: Professor Roy Fleischmann

Professor Roy Fleishmann, clinical professor of medicine at the University of Texas Southwestern Medical Center.

18th November 2021

Discussing Rheumatology: Herpes Zoster and HBV

Prof Iain McInnes discusses the risk of herpes zoster in RA patients taking biologics and DMARDS. He also discusses reactivation of hepatitis B in patients with RA taking tofacitinib.

31st October 2021

Rheumatology Author Professor Paul Bird: Tofacitinib Effectiveness

Paul Bird, Conjoint Professor at the University of South Wales joins Professor Peter Nash, where he discusses real-world data of tofacitinib therapy in RA

15th October 2021

Discussing Rheumatology: Poor Prognostic Factors, Monotherapy, and Combination Therapy

Prof Iain McInnes discusses poor prognostics factors from the FINCH 3 study, and the effectiveness and persistence of monotherapy and combination therapy from the Australian OPAL study.

23rd September 2021

All podcasts